[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355035-105":59,"doc-detail-355035-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","subsequent-primary-cancer-risks-for-non-hereditary-colorectal-cancer-survivors","Subsequent primary cancer risks for non-hereditary colorectal cancer survivors","","Colorectal cancer survivors face elevated risks of subsequent primary cancers, yet evidence is often limited to those with hereditary colorectal cancer syndromes. This multicountry cohort study quantified standardized incidence ratios for subsequent primary cancer in survivors without known hereditary predisposition. Using registry-linked follow-up data, overall subsequent primary cancer risk was not increased, while early-onset colorectal cancer and specific sites, including colorectal, hematopoietic, liver, and thyroid cancers, showed higher risks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/subsequent-primary-cancer-risks-for-non-hereditary-colorectal-cancer-survivors/355035/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/subsequent-primary-cancer-risks-for-non-hereditary-colorectal-cancer-survivors/355035.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Who was included in the study and how were participants selected?","Question",{"text":112,"@type":113},"The study analyzed data from the Colon Cancer Family Registry Cohort, recruiting participants between 1998 and 2012 and following them every five years. Individuals with pathogenic germline mutations in APC, MUTYH, or DNA mismatch repair genes were excluded.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Did non-hereditary colorectal cancer survivors have an increased overall risk of subsequent primary cancers?",{"text":117,"@type":113},"No. Overall subsequent primary cancer risk was not increased (SIR 1.04, 95% CI 0.98–1.11).",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancer sites and which patient group showed higher subsequent primary cancer risks?",{"text":121,"@type":113},"Elevated risks were observed for subsequent primary colorectal (SIR 1.34), hematopoietic (SIR 2.49), liver (SIR 2.25), and thyroid (SIR 1.90) cancers. Early-onset colorectal cancer cases diagnosed before age 50 had higher risks (SIR 1.43), while diagnoses at 50 and above did not.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355035,1790230476,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Articles  \nSubsequent primary cancer risks for non-hereditary colorectal cancer survivors  \nYe Kyaw Aung,a Mark A. Jenkins,a,j Nancy N. Baxter,b John D. Potter,d,e Stephanie L. Schmit,f,g Jewel J. Samadder,h Polly A. Newcomb,d,k Daniel D. Buchanan,c,i,j and Aung Ko Wina,c,j,∗  \naCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, 3010, Australia  \nbFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2050, Australia cFamilial Cancer Clinic, Genetic Medicine, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia dPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA eCentre for Public Health Research, Massey University, Wellington, New Zealand  \nfGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, 44195, USA  \ngDepartment of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH, 44195, USA  \nhDivision of Gastroenterology and Hepatology, Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, 85054, USA  \niColorectal Oncogenomic Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, 3010, Australia  \njCollaborative Centre for Genomic Cancer Medicine, Victorian Comprehensive Cancer Centre, Melbourne, VIC, 3000, Australia kSchool of Public Health, University of Washington, Seattle, WA, 98195, USA  \nSummary  \nBackground Colorectal cancer survivors have increased risks of subsequent primary cancers (SPCs), but most studies have included individuals with hereditary colorectal cancer syndromes. This study assessed SPC risks for colorectal cancer survivors without a known hereditary predisposition to colorectal cancer.  \nMethods We analyzed data from the Colon Cancer Family Registry Cohort, recruiting participants between 1998 and 2012 through population cancer registries in Australia, Canada and the United States, with follow-up every five years (until December 2022). Individuals with pathogenic germline mutations in APC, MUTYH, or DNA mismatch repair genes were excluded. Standardized incidence ratios (SIRs) were calculated by comparing observed cases with expected cases based on age-, sex-, country-, and calendar period-specific incidence rates.  \nFindings The study included 7202 (49.8% female) colorectal cancer survivors with a mean age at diagnosis of 55.1 (SD 11.5) years and a mean follow-up of 10.6 (SD 7.45) years. Overall, there was no evidence of increased SPC risk (SIR 1.04, 95% CI: 0.98–1.11) . Elevated risks were observed for subsequent primary colorectal (SIR 1.34, 95% CI: 1.14–1.57), hematopoietic (SIR 2.49, 95% CI: 1.92–3.21), liver (SIR 2.25, 95% CI: 1.51–3.36), and thyroid (SIR 1.90, 95% CI: 1.20–3.02) cancer. Early-onset colorectal cancer cases (diagnosed before age 50) had increased SPC risks (SIR 1.43, 95% CI: 1.25–1.64) while those diagnosed at 50 and above did not (p \u003C 0.001) .  \nInterpretation In non-hereditary colorectal cancer survivors, overall SPC risks are not elevated, but early-onset cases have higher risks and therefore warrant targeted surveillance and follow-up.  \nFunding National Institutes of Health (U01 CA167551) and National Health and Medical Research Council (1194392) .  \nCopyright © 2026 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \nKeywords: Colorectal cancer; Subsequent primary cancer; Extracolonic cancer; Hereditary colorectal cancer syndromes; Early-onset colorectal cancer  \nAbbreviations: APC, Adenomatous Polyposis Coli; CCFRC, The Colon Cancer Family Registry Cohort; ICD-O-3, The Third Edition ofthe International Classification of Disease for Oncology; MMR, Mismatch Repair gene; SIR, Standardized Incidence Ratios; SPC, Subsequent Primary Cancer  \n*Corresponding","cbCaihBQzJvhdf4H","https://ap.wps.com/l/cbCaihBQzJvhdf4H","pdf",909717,"English","# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n# Research in context\n## Evidence before this study\n## Added value of this study","[{\"question\":\"Who was included in the study and how were participants selected?\",\"answer\":\"The study analyzed data from the Colon Cancer Family Registry Cohort, recruiting participants between 1998 and 2012 and following them every five years. Individuals with pathogenic germline mutations in APC, MUTYH, or DNA mismatch repair genes were excluded.\"},{\"question\":\"Did non-hereditary colorectal cancer survivors have an increased overall risk of subsequent primary cancers?\",\"answer\":\"No. Overall subsequent primary cancer risk was not increased (SIR 1.04, 95% CI 0.98–1.11).\"},{\"question\":\"Which cancer sites and which patient group showed higher subsequent primary cancer risks?\",\"answer\":\"Elevated risks were observed for subsequent primary colorectal (SIR 1.34), hematopoietic (SIR 2.49), liver (SIR 2.25), and thyroid (SIR 1.90) cancers. Early-onset colorectal cancer cases diagnosed before age 50 had higher risks (SIR 1.43), while diagnoses at 50 and above did not.\"}]","Subsequent primary cancer risks for non-hereditary colorectal cancer survivors | PDF",1790115522,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3d4e406cd17bab5d135575a3cd4574e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c00e04b0122a339a520b7bcb9b1b714.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/592503110fa3909ca1cd1978e2febbce.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20bee3555066ae47cae6cf05eeae0f23.webp",980,1306]